Diadema Partners’s PureTech Health PRTC Stock Holding History

Diadema Partners’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,924	Closed	-$11.3K	–	186
2026 Q1	$11.3K	Buy	7,924 +482	+6%	+$8.37K	﹤0.01%	137
2025 Q4	$124K	Buy	7,442 +118	+2%	+$2.03K	0.02%	135
2025 Q3	$135K	Hold	7,324	–	–	0.03%	117
2025 Q2	$126K	Buy	+7,324	New	+$129K	0.04%	89

Diadema Partners's PRTC Position: Q2 2026 in Review

Diadema Partners sold out of PureTech Health (PRTC) in Q2 2026, closing a stake of 7,924 shares — an estimated $11.3K sold.

Diadema Partners first reported a position in PRTC in Q2 2025 and held it in 4 quarters. The position peaked at $135K in Q3 2025. 0 funds tracked by Wall St. Rank hold PRTC as of Q2 2026.

Diadema Partners reported no remaining PureTech Health position as of Q2 2026 after selling out during the quarter.
Diadema Partners sold 7,924 PureTech Health shares in Q2 2026, an estimated $11.3K.
Diadema Partners first reported a position in PureTech Health in Q2 2025 and held it in 4 quarters.
Diadema Partners's PureTech Health position peaked at $135K in Q3 2025.
0 funds tracked by Wall St. Rank held PureTech Health as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.